---

---

tags : Presentation   

save search

---

Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
TLSA | News | $0.6199 20.84% 17.24% 1.5M |

Health Technology

| 47.13% | O: 1.15% H: 9.66% C: 3.34%
life presentation foralumab sciences meeting imaging platform

---

Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties
Published: 2024-04-10 (Crawled : 12:30) - prnewswire.com
MBRX | News | $4.59 7.24% 6.75% 50K |

Health Technology

| -13.58% | O: 8.8% H: 3.87% C: -8.61%
presentation positive

---

Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024
Published: 2024-04-09 (Crawled : 20:00) - prnewswire.com
FUSN | $21.24 0.0% 330K |

Health Technology

| -0.65% | O: -0.19% H: 0.28% C: 0.09%
fpi-2265 presentation pharmaceuticals meeting trial

---

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
STTK | $10.11 0.9% 0.89% 430K |

Health Technology

| 11.33% | O: -1.11% H: 9.78% C: 9.66%
association presentation cancer research preclinical for meeting

---

Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
TRVI | $2.68 3.88% 3.73% 180K |

Health Technology

| -12.23% | O: 2.77% H: 1.59% C: -8.57%
conference presentation international therapeutics

---

Invitation presentation of Boliden's Q1 2024 report
Published: 2024-04-09 (Crawled : 11:00) - prnewswire.com
BDNNY | $63.42 0.42% 9.6K |

n/a

| -0.78% | O: 3.55% H: 0.4% C: -0.35%
report presentation

---

Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform
Published: 2024-04-08 (Crawled : 21:00) - globenewswire.com
THTX | $1.32 -12.78% 10K |

Health Technology

| -4.96% | O: 4.96% H: 4.05% C: 4.05%
presentation preclinical platform

---

Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
TOVX | $0.4475 2.87% 0.11% 29K |

Manufacturing

| -4.02% | O: 0.62% H: 2.02% C: -1.11%
presentation cell for meeting therapy

---

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Published: 2024-04-07 (Crawled : 00:00) - globenewswire.com
BDTX A | $5.295 -7.11% -7.65% 1.9M |

Health Technology

| 8.03% | O: 5.22% H: 3.44% C: 2.1%
bdtx-1535 association presentation cancer research for meeting therapeutics

---

Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-04-07 (Crawled : 00:00) - globenewswire.com
REPL | $6.98 -3.19% -3.3% 1.1M |

Health Technology

| 0.21% | O: 3.27% H: 0.13% C: -4.17%
association presentation cancer cell research meeting skin trial results

---

NexPoint Diversified Real Estate Trust Releases Investor Presentation
Published: 2024-04-04 (Crawled : 12:30) - prnewswire.com
NXDT | $6.29 1.62% 0.0% 170K |

| 3.69% | O: 1.84% H: 2.47% C: -0.49%
presentation trust

---

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-03 (Crawled : 11:00) - globenewswire.com
ATHA | $2.07 -1.9% -1.93% 200K |

Health Technology

| -16.94% | O: -3.23% H: 0.0% C: 0.0%
pharma presentation meeting

---

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)
Published: 2024-04-02 (Crawled : 23:00) - globenewswire.com
MNOV | $1.445 1.05% 1.04% 21K |

Health Technology

| -6.04% | O: 2.01% H: 4.61% C: 0.0%
mn-166 presentation meeting trial results glioblastoma

---

Kyowa Kirin Announces Acceptance of Abstract for Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
Published: 2024-04-02 (Crawled : 22:00) - biospace.com/
AVEO | $15.0 0.0% 0 |

Health Technology

| Email alert Add to watchlist
association presentation research vision meeting

---

Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
VRCA | $6.91 -2.13% -2.17% 200K |

Health Technology

| 25.62% | O: -0.36% H: 6.25% C: 5.18%
conference presentation pharmaceuticals

---

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
TCRX 1 d | $6.9 2.22% 2.17% 250K |

Professional, Scientific, and T...

| -16.62% | O: -1.3% H: 0.0% C: -9.89%
conference presentation therapeutics

---

Virco Issues Updated Investor Presentation
Published: 2024-04-01 (Crawled : 12:30) - globenewswire.com
VIRC | $10.36 0.39% 0.39% 120K |

Producer Manufacturing

| -5.58% | O: 1.37% H: 0.0% C: 0.0%
presentation

---

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
CADL | $5.49 0.92% 0.91% 740K |

| Email alert Add to watchlist
can-3110 drug presentation update trial therapeutics glioblastoma

---

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-03-28 (Crawled : 20:00) - prnewswire.com
HRTX | $2.71 -2.17% -2.21% 1.8M |

Health Technology

| Email alert Add to watchlist
conference presentation therapeutics

---

Biond Biologics Announces Presentation of BND-35, a Novel Anti-ILT3 Antibody for Remodeling the Tumor Microenvironment, at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -5.72% | O: 1.93% H: 0.0% C: 0.0%
bnd-35 antibody association presentation cancer tumor research meeting

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---